Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$27.00 – $27.25
100% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $671.6M | $844.4M | $997.8M | $1.38B | $1.51B | $1.75B | $2.09B | $2.38B |
| Cost of revenue | $510.9M | $637.6M | $734.3M | $982.4M | $1.17B | $1.39B | $1.64B | $1.83B |
| Gross profit | $160.7M | $206.8M | $263.5M | $395.0M | $335.6M | $359.4M | $448.3M | $550.7M |
| Gross margin | 23.9% | 24.5% | 26.4% | 28.7% | 22.2% | 20.6% | 21.4% | 23.2% |
| R&D | $0 | $1.5M | $2.3M | $2.7M | $4.3M | $0 | $7.0M | $0 |
| Operating income | $29.4M | $46.5M | $61.3M | $159.4M | $55.5M | $61.4M | $70.3M | $155.7M |
| EBITDA | $61.8M | $121.2M | $151.6M | $274.9M | $215.9M | $257.4M | $171.2M | $377.7M |
| Net income | $24.6M | $22.5M | $25.8M | $101.8M | $11.8M | $17.6M | $16.7M | $77.5M |
| Net margin | 3.7% | 2.7% | 2.6% | 7.4% | 0.8% | 1.0% | 0.8% | 3.3% |
| EPS (diluted) | 0.18 | 0.17 | 0.19 | 0.67 | 0.08 | 0.12 | 0.11 | 0.51 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.6B | $0.68 | $0.66–$0.71 | 1 |
| 2027 | $2.9B | $0.88 | $0.85–$0.92 | 1 |
| 2028 | $3.2B | $1.08 | $1.05–$1.13 | 1 |
| 2029 | $3.6B | $1.38 | $1.33–$1.44 | 1 |
Forward consensus · source: Financial Modeling Prep
MEDICOVER AB SHARES AK B
No one on the platform currently holds MCVEF.
No tracked institution reports a position in MCVEF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-04 | $0.2000 | 2026-05-11 |
| 2025-05-02 | $0.1500 | 2025-05-09 |
| 2024-04-29 | $0.1200 | 2024-05-08 |
No one on the platform has traded MCVEF yet.
| $743M |
| — |
| MCRPFMicroPort Scientific Corporation | $0.85 | -10.79% | $1.6B | — |
| RHCGFRyman Healthcare Limited | $1.08 | +0.00% | $1.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.